These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23567263)

  • 1. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt isoform-specific inhibition of MDA-MB-231 cell proliferation.
    Yang W; Ju JH; Lee KM; Shin I
    Cell Signal; 2011 Jan; 23(1):19-26. PubMed ID: 20688159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
    Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
    Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
    Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
    Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
    Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
    Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion.
    Wang S; Basson MD
    Exp Cell Res; 2008 Jan; 314(2):286-96. PubMed ID: 17825284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
    Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
    Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.
    Sasaki T; Nakashiro K; Tanaka H; Azuma K; Goda H; Hara S; Onodera J; Fujimoto I; Tanji N; Yokoyama M; Hamakawa H
    Biochem Biophys Res Commun; 2010 Aug; 399(1):79-83. PubMed ID: 20638364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
    Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
    Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
    Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
    Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
    Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
    Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
    Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells.
    Santi SA; Lee H
    PLoS One; 2011 Jan; 6(1):e14614. PubMed ID: 21297943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
    Riggio M; Perrone MC; Polo ML; Rodriguez MJ; May M; Abba M; Lanari C; Novaro V
    Sci Rep; 2017 Mar; 7():44244. PubMed ID: 28287129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
    Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.